Bibliographies

Tanaka R, Imai J, Sugiyama E, Tsubaki S, Hozumi K, Tsugawa H*. Cyclic-di-AMP confers an invasive phenotype on Escherichia coli through elongation of flagellin filaments. Gut Pathogens, 16: 6, 2024. *Corresponding author, IF: 5.324

Tsugawa H*, Ohki T, Tsubaki S, Tanaka R, Matsuzaki J, Suzuki H, Hozumi K. Gas6 ameliorates intestinal mucosal immunosenescence to prevent the translocation of a gut pathobiont, Klebsiella pneumoniae, to the liver. PLoS Pathogens, 19(6): e1011139, 2023. * Corresponding author. IF: 7.464 

Matsui H, Rimbara E, Suzuki M, Tokunaga K, Suzuki H, Sano M, Ueda T, Tsugawa H, Nanjo S, Takeda A, Sasaki M, Terao S, Suda T, Aoki S, Shibayama K, Ota H, Mabe K. Development of serological assays to identify Helicobacter suis and Helicobacter pylori infections. iScience, 106522, 2023. IF6.107

Tanaka R, Imai J, Tsugawa H,  Eap Bil K, Yazawa M, Kaneko M, Ohno M, Sugihara K, Kitamoto S, Nagao-Kitamoto H, Barnich N, Matsushima M, Suzuki T, Kagawa T, Nishizaki Y, Suzuki H, Kamada N, Hozumi K. Adherent-invasive E. coli – induced specific IgA limits pathobiont localization to the epithelial niche in the gut. Frontiers in Microbiology, 14: 1031997, 2023. IF6.064

Kabe Y, Koike I, Yamamoto T, Hirai M, Kanai A, Furuhata R, Tsugawa H, Harada E, Sugase K, Hanadate K, Yoshikawa N, Hayashi H, Noda M, Uchiyama S, Yamazaki H, Tanaka H, Kobayashi T, Handa H, Suematsu M. Glycyrrhizin Derivatives Suppress Cancer Chemoresistance by Inhibiting Progesterone Receptor Membrane Component 1. Cancers, 13(13): 3265, 2021.  IF6.639

Tsugawa H, Kabe Y, Kanai A, Sugiura Y, Hida S, Taniguchi S, Takahashi T, Matsui H, Yasukawa Z, Itou H, Takubo K, Suzuki H, Honda K, Handa H, Suematsu M. Short-chain fatty acids bind to apoptosis-associated speck-like protein to activate inflammasome complex to prevent Salmonella infection. PLoS Biology. 18(9): e3000813, 2020. IF7.08

Furuhata R, Kabe Y, Kanai A, Sugiura Y, Tsugawa H, Sugiyama E, Hirai M, Koseki M, Nakae J, Matsumoto M, Nakamura M, Suematsu M. Progesterone receptor membrane associated component 1 enhances obesity progression in mice by facilitating lipid accumulation in adipocytes. Commun. Biol., 3: 479, 2020.  IF6.548

Tsugawa H, Kato C, Mori H, Matsuzaki J, Kameyama K, Saya H, Hatakeyama M, Suematsu M, Suzuki H. Cancer stem-cell marker CD44v9-positive cells arise from Helicobacter pylori-infected CAPZA1-overexpressing cells. Cell. Mol. Gastroenterol. Hepatol., 8(3): 319-334, 2019. IF:7.076

Matsuzaki J*, Tsugawa H*, Kashiwazaki Y, Mori H, Yamamoto Y, Kameyama H, Masaoka T, Kanai T, Suzuki H. Neutrophil-activating protein polymorphism of Helicobacter pylori determines the host risk of dyspepsia. Cell. Mol. Gastroenterol. Hepatol., 8(2): 295-297, 2019. *Contributed equally to this work. IF:7.076

Tsugawa H, Mori H, Matsuzaki J, Sato A, Saito Y, Imoto M, Suematsu M, Suzuki H. CAPZA1 determines the risk of gastric carcinogenesis by inhibiting Helicobcater pylori CagA-degraded autophagy. Autophagy, 15(2): 242-258, 2019. IF:9.770

Miyoshi S, Tsugawa H, Matsuzaki J, Hirata K, Mori H, Saya H, Kanai T, Suzuki H. Inhibiting xCT Improves 5-Fluorouracil Resistance of Gastric Cancer Induced by CD44 Variant 9 Expression. Anticancer Res., 38: 6163-6170, 2018. IF:1.994

Fukuhara S, Masaoka T, Nishimura S, Nakamura M, Matsuzaki J, Tsugawa H, Miyoshi S, Mori H, Kawase S, Shibata S, Okano H, Kanai T, Suzuki H. Enteric Glial Dysfunction Evoked by Apolipoprotein E Deficiency Contributes to Delayed Gastric Emptying. Dig. Dis. Sci., 62(12): 3359-3369, 2017. IF:2.751

Pati ML, Groza D, Riganti C, Kopecka J, Niso M, Berardi F, Hager S, Heffeter P, Hirai M, Tsugawa H, Kabe Y, Suematsu M, Abate C. Sigma-2 receptor and progesterone receptor membrane component 1 (PGRMC1) are two different proteins: Proofs by fluorescent labeling and binding of sigma-2 receptor ligands to PGRMC1. Pharmacol. Res., 117: 67-74, 2017. IF:5.893

Mori H, Suzuki H, Matsuzaki J, Tsugawa H, Fukuhara S, Miyoshi S, Hirata K, Seino T, Matsushita M, Nishizawa T, Masaoka T, Kanai T. Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: A pilot study. United European Gastroenterol. J., 4(3): 380-387, 2016. IF: 3.549

Mori H, Suzuki H, Matsuzaki J, Tsugawa H, Fukuhara S, Miyoshi S, Hirata K, Seino T, Matsushita M, Masaoka T, Kanai T. Efficacy of 10-day Sitafloxacin-containing third-line rescue therapies for Helicobacter pylori strains containing the gyrA mutation. Helicobacter, 21(4): 286-294, 2016. IF:4.000

Akazawa Y, Matsuda K, Isomoto H, Matsushima K, Kido Y, Urabe S, Yamaghchi N, Ohnita K, Takeshima F, Kondo H, Tsugawa H, Suzuki H, Moss J, Nakao K, Nakashima M. BH3-only protein Bim is associated with the degree of Helicobacter pylori-induced gastritis and is localized to the mitochondria of inflammatory cells in the gastric mucosa. Int. J. Med. Microbiol., 305:553-62, 2015. IF:3.113

Tsugawa H, Mori H, Matsuzaki J, Masaoka T, Hirayama T, Nagasawa H, Sakakibara Y, Suematsu M, Suzuki H. Nordihydroguaiaretic Acid disrupts the antioxidant ability of Helicobacter pylori through the repression of SodB activity in vitro. Biomed. Res. Int., 734548, 2015. IF:2.276

Fukuhara S, Matsuzaki J, Tsugawa H, Masaoka T, Miyoshi S, Mori H, Fukushima Y, Yasui M, Kanai T, Suzuki H. Mucosal expression of aquaporin-4 in the stomach of histamine type 2 receptor knockout mice and Helicobacter pylori-infected mice. J. Gastroenterol. Hepatol., 29 (Suppl 4):53-59, 2014. IF:3.437

Matsuzaki J, Suzuki H, Tsugawa H, Watanabe M, Hossain S, Arai E, Saito Y, Sekine S, Akaike T, Kanai Y, Mukaisho K, Auwerx J, Hibi T. Bile acids increase levels of MicroRNAs 221 and 222, leading to degradation of CDX2 during esophageal carcinogenesis. Gastroenterology, 145(6):1300-1311, 2013. IF:17.373

Hirata K, Suzuki H, Imaeda H, Matsuzaki J, Tsugawa H, Nagano O, Asakura K, Saya H, Hibi T. CD44 variant 9 expression in primary early gastric cancer as a predictive marker for recurrence. Br. J. Cancer, 109(2):379-386, 2013. IF:5.791

Mogami S, Suzuki H, Tsugawa H, Fukuhara S, Hibi T. Impaired heme oxygenase-1 induction in the gastric antrum induces disruption of the interstitial cells of Cajal network in a rat model of storeptozotocin-induced diabetes. Neurogastroenterol. Motil., 25(7): 609-e465, 2013. IF:2.946

Saito Y, Suzuki H, Imaeda H, Matsuzaki J, Hirata k, Tsugawa H, Hibino S, Kanai Y, Saito H, Hibi T. The tumor suppressor microRNA-29c is downregulated and restored by celecoxib in human gastric cancer cells. Int. J. Cancer, 132(8):1751-1760, 2013. IF:5.145

Tsugawa H, Suzuki H, Saya H, Hatakeyama M, Hirayama T, Hirata K, Nagano O, Matsuzaki J, Hibi T. Reactive oxygen species-induced autophagic degradation of Helicobacter pylori CagA is specifically suppressed in cancer stem-like cells. Cell Host Microbe, 12(6):764-777, 2012. IF:15.923

Saito Y, Suzuki H, Tsugawa H, Imaeda H, Matsuzaki J, Hirata K, Hosoe N, Nakamura M, Mukai M, Saito H, Hibi T. Overexpression of miR-142-5p and miR-155 in gastric mucosa-associated lymphoid tissue (MALT) lymphoma resistant to Helicobacter pylori eradication. PLoS One, 7(11):e47396, 2012. IF:2.740

Saito Y, Suzuki H, Taya T, Nishizawa M, Tsugawa H, Matsuzaki J, Hirata K, Saito H, Hibi T. Development of a novel microRNA promoter microarray for ChiP-on-chip assay to identify epigenetically regulated microRNAs. Biochem. Biophys. Res. Commun., 426(1):33-37, 2012. IF:2.985

Tsugawa H, Suzuki H, Matsuzaki J, Hirata K, Hibi T. FecA1, a bacterial iron transporter, determines the survival of Helicobacter pylori in the stomach. Free Radic. Biol. Med., 52(6):1003-1010, 2012. IF:6.170

Matsuzaki J, Suzuki H, Nishizawa T, Hirata K, Tsugawa H, Saito Y, Okada S, Fukuhara S, Hibi T. Efficacy of sitafloxacin-based rescue therapy for Helicobacter pylori after failures of first- and second-line therapies. Antimicrob. Agents Chemother., 56(3): 1643-1645, 2012. IF:4.904

Nishizawa T, Suzuki H, Matsuzaki J, Muraoka H, Tsugawa H, Hirata K, Hibi T. Helicobacter pylori resistance to rifabutin in the last 7 Years. Antimicrob. Agents Chemother., 55(11):5374-5375, 2011. IF:4.904

Nishizawa T, Suzuki H, Tsugawa H, Muraoka H, Matsuzaki J, Hirata K, Ikeda F, Takahashi M, Hibi T. Enhancement of amoxicillin resistance after unsuccessful Helicobacter pylori eradication. Antimicrob. Agents Chemother., 55(6):3012-3014, 2011. IF:4.904

Tsugawa H, Suzuki H, Muraoka H, Ikeda F, Hirata K, Matsuzaki J, Saito Y, Hibi T. Enhanced bacterial efflux system is the first step to the development of metronidazole resistance in Helicobacter pylori. Biochem. Biophys. Res. Commun., 404(2):656-660, 2011. IF:2.985

Saito Y, Suzuki H, Tsugawa H, Suzuki S, Matsuzaki J, Hirata K, Hibi T. Dysfunctional gastric emptying with down regulation of muscle-specific microRNAs in Helicoabctr pylori-infected mice. Gastroenterology, 140(1):189-198, 2011. IF:17.373

Tsugawa H, Suzuki H, Satoh K, Hirata K, Matsuzaki J, Saito Y, Suematsu M, Hibi T. Two amino acids mutation of Ferric uptake regulator (Fur) determines Helicobacter pylori resistance to metronidazole. Antioxid. Redox Signal., 14(1):15-23, 2011. IF:6.323

Matsuzaki J, Suzuki H, Tsugawa H, Nishizawa T, Hibi T. Homology model of the DNA gyrase enzyme of Helicobacter pylori, a target of quinolone-based eradication therapy. J. Gastroenterol. Hepatol., Suppl1:S7-S10, 2010. IF:3.437

Hirata K, Suzuki H, Nishizawa T, Tsugawa H, Muraoka H, Saito Y, Matsuzaki J, Hibi T. Contribution of efflux pumps to clarithromycin resistance in Helicobacter pylori. J. Gastroenterol. Hepatol., Suppl1:S75-S79, 2010. IF:3.437

Matsuzaki J, Suzuki H, Minegishi Y, Sugai E, Tsugawa H, Yasui M, Hibi T. Acid Suppression by Proton Pump Inhibitors Enhances Aquaporin-4 and KCNQ1 Expression in Gastric Fundic Parietal Cells in Mouse. Dig. Dis. Sci., 55(12):3339-33348, 2010. IF:2.751

Suzuki S, Suzuki H, Horiguchi K, Tsugawa H, Matsuzaki J, Takagi T, Shimojima N, Hibi T. Delayed gastric emptying and disruption of the interstitial cells of Cajal network after gastric ischaemia and reperfusion. Neurogastroenterol. Motil., 22(5):585-593, 2010. IF:2.946

Saito Y, Suzuki H, Tsugawa H, Nakagawa I, Matsuzaki J, Kanai Y, Hibi T. Chromatin remodeling at Alu repeats by epigenetic treatment activates silenced microRNA-512-5p with downregulation of Mcl-1 in human gastric cancer cells. Oncogene, 28(30):2738-2744, 2009. IF:7.971

Tsugawa H, Suzuki H, Nakagawa I, Nishizawa T, Saito Y, Suematsu M, Hibi T. Alpha-ketoglutarate oxidoreductase, an essential salvage enzyme of energy metabolism, in coccoid form of Helicobacter pylori. Biochem. Biophys. Res. Commun., 376(1):46-51, 2008. IF:2.985

Tsugawa H, Ogawa A, Takehara S, Kimura M, Okawa Y. Primary structure and function of a cytotoxic outer-membrane protein (ComP) of Plesiomonas shigelloides. FEMS Microbiol. Lett., 281(1):10-16, 2008. IF:1.987

Tsugawa H, Ito H, Ohshima M, Okawa Y. Cell adherence-promoted activity of Plesiomonas shigelloides GroEL. J. Med. Microbiol., 56:23-29, 2007. IF:2.156

Tsugawa H, Ono H, Murakami H, Okawa Y. Invasive phenotype and apoptosis induction of Plesiomonas shigelloides P-1 strain to Caco-2 cells. J. Appl. Microbiol., 99(6):1435-1443, 2005. IF:3.066

Okawa Y, Ohtomo Y, Tsugawa H, Matsuda Y, Kobayashi H, Tsukamoto T. Isolation and characterization of a cytotoxin produced by Plesiomonas shigelloides P-1 strain. FEMS Microbiol. Lett., 239(1):125-130, 2004. IF: 1.987

津川仁. 腸管粘膜常在マクロファージによる消化管内共生病原菌クレブシエラの認識・制御機構の解明. 公益財団法人大山健康財団年報, 48: 23-25, 2023.

津川仁. 短鎖飽和脂肪酸：新しいガスメディエータによる免疫機能制御. 細胞, 54:8-11, 2022. 

津川仁. 胃がんの発症を制御する胃内の細菌. 日本がん予防学会News Letter, 107:4, 2021. 

津川仁. H. pylori病原性, 病態発生の最新知見. 日本ヘリコバクター学会誌, 23(1) 17, 2021. 

Klionsky DJ. et al. (2481番目/2929人中), Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition). Autophagy, 17(1):1-382, 2021.

津川仁. ピロリ菌感染と宿主免疫応答. 血液内科, 80: 803-810, 2020.

津川仁. Helicobacter pylori傷害機序の新知見. Helicobacter Research, 24: 25-37, 2020.

Matsuzaki J, Tsugawa H, Suzuki H. Precision Medicine Approaches to Prevent Gastric Cancer. Gut and Liver, 15(1):3-12. 2020,

津川仁. マイクロバイオータとH. pylori感染. 日本ヘリコバクター学会誌, 20(2): 112-117, 2019.

津川仁, 鈴木秀和. 新興・再興感染症[4] H. pylori感染症を制御する病原因子と宿主細胞応答. 日本防菌防黴学会誌, 46: 27−32, 2018.

Kabe Y, Yamamoto T, Kajimura M, Sugiura Y, Koike I, Ohmura M, Nakamura T, Tokumoto Y, Tsugawa H, Handa H, Kobayashi T, Suematsu M. Cystathionine β-synthase and PGRMC1 as CO sensors. Free Radic. Biol. Med., 99: 333-344, 2016.

津川仁, 鈴木秀和. H. pylori感染症と宿主免疫応答. 臨床と微生物, 42: 125-130, 2015.

鈴木秀和, 津川仁. Helicobacter pylori感染とオートファジー. G.I.Reserch. 23: 227-231, 2015.

森英毅, 津川仁, 正岡建洋, 金井隆典, 佐谷秀行, 鈴木秀和. CD44v9陽性胃癌細胞におけるトラスツズマブ耐性化獲得機構. GI Research. 23(4): 362-363, 2015.

津川仁. ピロリ菌の感染戦略と胃がん発症に関わる宿主応答機構の解析. 日本細菌学雑誌, 69(4): 565-575, 2014.

津川仁, 鈴木秀和. 宿主細胞が魅せる酸化ストレスを介したCagA排除応答. Journal of Helicobacter Research, 17(5): 46-50, 2014.

森英毅, 鈴木秀和, 津川仁, 正岡建洋, 三好佐和子, 福原誠一郎, 金井隆典, 佐谷秀行. HER2陽性胃がんにおいてCD44v9はトラスツズマブ耐性を獲得する. GI Research. 22(4): 402-403, 2014.

岡田佐和子, 鈴木秀和, 正岡建洋, 津川仁, 松崎潤太郎, 平田賢郎, 福原誠一郎, 森英毅, 佐谷秀行, 日比紀文. 胃がん細胞のCD44 variant 9発現による酸化ストレス抵抗性獲得と5-FU耐性化. GI Research. 21(4): 394-395, 2013.

津川仁, 鈴木秀和, 佐谷秀行, 畠山昌則, 平山壽哉, 松崎潤太郎, 平田賢郎, 福原誠一郎, 岡田佐和子, 日比紀文. m1VacA依存性ROS産生亢進によるoncoprotein CagA分解性autophagy発動機構. 日本ヘリコバクター学会誌. 14(2):15-18, 2013.

Suzuki H, Nishizawa T, Tsugawa H, Hibi T. Molecular approaches and modern clinical strategies for the management of Helicobacter pylori infection in Japan. Keio J. Med., 61(4): 109-119, 2012.

Suzuki H, Nishizawa T, Tsugawa H, Mogami S, Hibi T. Roles of oxidative stress in stomach disorders. J. Clin. Biochem. Nutr., 50(1): 35-39, 2012.

津川仁, 鈴木秀和. ピロリ菌のもつがん蛋白質CagAは酸化ストレスにより誘導されるオートファジーにより分解される. ライフサイエンス新着論文レビュー(http://first.lifesciencedb.jp/), 2012年12月28日

津川仁, 鈴木秀和, 畠山昌則, 平山壽哉, 松崎潤太郎, 平田賢郎, 福原誠一郎, 岡田佐和子, 日比紀文. ミトコンドリア由来ROS依存性autophagyによる胃粘膜上皮のH. pylori由来がん蛋白質CagA排除システム. G.I.Reserch, 20:98-99, 2012.

津川仁, 鈴木秀和,畠山昌則,平山壽哉,松崎潤太郎,平田賢郎,福原誠一郎,岡田佐和子,日比紀文. Helicobacter pylori感染細胞のoncoprotein CagA排除システム. 日本ヘリコバクター学会誌, 13(2):40-43, 2012.

鈴木秀和, 津川仁, 日比紀文. ヘリコバクター・ピロリ感染症と酸化ストレス. BIO Clinica. 27: 324-327, 2012.

鈴木秀和, 津川仁, 日比紀文. H. pyloriの病原・薬剤耐性機序～慢性持続性感染による宿主応答から～ ヘリコバクター・ピロリ感染症の徹底検証 ライフ・サイエンス. 39-53, 2012.

福原誠一郎, 鈴木秀和, 松崎潤太郎, 津川仁, 平田賢郎, 岡田佐和子, 日比紀文. 酸分泌抑制状態における壁細胞のaquaporin 4の発現動態. 潰瘍. 39(2): 121-123, 2012.

西澤俊宏, 鈴木秀和, 津川仁, 村岡宏江, 松崎潤太郎, 平田賢郎, 池田文昭, 高橋正彦, 日比紀文. H. pylori除菌不成功によるアモキシリン耐性化とPBP1遺伝子変異. 日本ヘリコバクター学会誌. 13(2): 47-49, 2012.

津川仁, 鈴木秀和, 日比紀文. 酸化ストレス研究により明らかになったHelicobacter pylori薬剤耐性獲得機構. G.I.Reserch, 19:38-43, 2011.

Suzuki H, Nishizawa T, Tsugawa H, Hibi T. Free Radicals in Helicobacter pylori infection. Front Gastrointest. Res., 29: 111-120, 2011.

福原誠一郎, 鈴木秀和, 松崎潤太郎, 斎藤義正, 津川仁, 平田賢郎, 岡田佐和子, 鈴木雅之, 日比紀文. 酸分泌低下と壁細胞のaquaporin4、KCNQ1発現. 潰瘍. 38(2): 170-172, 2011.

福原誠一郎, 鈴木秀和, 津川仁, 松崎潤太郎, 岡田佐和子, 平田賢郎, 内田勝幸, 日比紀文. Streptozotocin惹起糖尿病ラットにおける胃粘膜酸化ストレスと胃運動異常に対すrebamipideの効果. GI Research. 19(4): 404-405, 2011.

平田賢郎, 鈴木秀和, 斉藤義正, 津川仁, 松崎潤太郎, 福原誠一郎, 岡田佐和子, 今枝博之, 日比紀文. microRNAの発現異常と癌化シグナル. 潰瘍. 38(2): 121-124, 2011.

津川仁, 鈴木秀和, 平田賢郎, 松崎潤太郎, 鈴木祥子, 斎藤義正, 日比紀文. Helicobacter pyloriの抗酸化能に寄与する転写制御因子Ferric uptake regulator (Fur)の役割と鉄代謝. G.I.Reserch, 18:114-115, 2010.

鈴木秀和, 鈴木雅之, 森三樹二, 西澤俊宏, 斎藤義正, 津川仁, 正岡建洋, 日比紀文. 感染症と消化性潰瘍. 潰瘍. 37: 7-11, 2010.

斎藤義正, 鈴木秀和, 津川仁, 松崎潤太郎, 平田賢郎, 日比紀文. API2-MALT1キメラ遺伝子陽性胃MALTリンパ腫におけるマイクロRNA発現異常. 潰瘍. 37(1): 23-27, 2010.

斎藤義正, 鈴木秀和, 津川仁, 松崎潤太郎, 日比紀文. API2-MALT1キメラ遺伝子陽性胃MALTリンパ腫におけるマイクロRNA発現異常. 日本ヘリコバクター学会誌. 11(2): 39-42, 2010.

津川仁, 鈴木秀和, 斎藤義正, 日比紀文. メトロニダゾール耐性H. pyloriにおける転写制御因子Ferric uptake regulator (Fur)依存的な抗酸化能と鉄代謝. 潰瘍. 37: 43-44, 2010.

津川仁, 鈴木秀和, 佐藤和恵, 平田賢朗, 西澤俊宏, 鈴木雅之, 斎藤義正, 日比紀文. H. pyloriのメトロニダゾール耐性に寄与するFerric uptake regulator (Fur)の構造的,機能的異常. 日本ヘリコバクター学会誌, 11(2):47-48, 2010.

津川仁, 鈴木秀和, 中川いずみ, 平田賢郎, 鈴木祥子, 松崎潤太郎, 岩崎栄典, 斉藤義正, 日比紀文. Helicobacter pyloriの酸化ストレスセンサー異常による薬剤耐性機序. G.I.Reserch, 17:96-97, 2009.

津川仁, 鈴木秀和, 平田賢朗, 斎藤義正, 西澤俊宏, 岩崎栄典, 鈴木雅之, 末松誠, 日比紀文. Helicobacter pyloriのnitroreductase (RdxA)非依存性メトロニダゾール耐性機序. Progress in Medicine, 29:749-750, 2009.

岩崎栄典, 鈴木秀和, 正岡建洋, 鈴木祥子, 高橋哲史, 斎藤義正, 津川仁, 西澤俊宏, 日比紀文. 機能性ディスペプシアにみられる胃排出障害動物モデルでのグレリン動態. 潰瘍. 35(1): 17-19, 2008.

津川仁, 鈴木秀和, 中川いずみ, 高橋哲史, 西澤俊宏, 岩崎栄典, 正岡建洋, 斉藤義正, 末松誠, 日比紀文. Helicobacter pyloriのcoccoid formにおける代謝について. Progress in Medicine, 28:732-734, 2008.

津川仁. 胃がんと非H. pylori細菌. 腸内微生物叢最前線, 診断と治療社, pp72-75, 2020.

津川仁. 消化管内共生微生物による胃癌幹細胞発生制御メカニズムの解明. ヤクルト・バイオサイエンス研究財団年報 第28号, 45-52, 2020.

Tsugawa H, Suzuki H. Gastric Carcinogenesis. In: Shiotani A. (eds) Gastric Cancer. Springer Book. 51-62, 2019.

Tsugawa H, Suzuki H. Autophagy. Helicobacter pylori, Springer Book. 67-71, 2016.

鈴木秀和, 津川仁, 松崎潤太郎, 畠山昌則. 109 消化器領域における炎症性発癌と喫煙　平成25年度　喫煙科学研究財団研究年報.　公益財団法人　喫煙科学研究財団. 554-560, 2015.

鈴木秀和, 津川仁, 日比紀文. ピロリ菌の薬剤耐性機序とその対策. Annual Review消化器2012. 13-18, 2012.